Literature DB >> 23312963

One stop screening for multiple cancers: the experience of an integrated cancer prevention center.

Tal Sella1, Ben Boursi, Amira Gat-Charlap, Ilan Aroch, Eliezer Liberman, Menachem Moshkowitz, Ehud Miller, Eyal Gur, Roy Inbar, Arye Blachar, Nicola J Mabjeesh, Olivia Rosenfeld, Fanny Sperber, Vadim Reiser, Shlomi Kleinman, Ariel J Jaffa, Miki Bloch, Mati Ormianer, Inna Naumov, Diana Kazanov, Sarah Kraus, Lior Galazan, Nadir Arber.   

Abstract

BACKGROUND: Cancer is a leading cause of mortality worldwide. Screening is a key strategy for reducing cancer morbidity and mortality.
METHODS: We aimed to describe the experience of an integrated cancer prevention center in screening an asymptomatic population for the presence of neoplasia. One-thousand consecutive asymptomatic, apparently healthy adults, aged 20-80 years, were screened for early detection of 11 common cancers that account for 70-80% of cancer mortality.
RESULTS: Malignant and benign lesions were found in 2.4% and 7.1% of the screenees, respectively. The most common malignant lesions were in the gastrointestinal tract and breast followed by gynecological and skin. The compliance rate for the different screening procedures was considerably higher than the actual screening rate in the general Israeli population - 78% compared to 60% for mammography (p<0.001) and 39% compared to 16% for colonoscopy (p<0.001). Advanced age, family history of cancer and certain lifestyle parameters were associated with increased risk. Moreover, polymorphisms in the APC and CD24 genes indicated high cancer risk. When two of the polymorphisms existed in an individual, the risk for a neoplastic lesion was extremely high (OR 2.3 [95% CI 0.94-5.9]).
CONCLUSIONS: One stop shop screening for 11 common cancers in the setting of a multidisciplinary outpatient clinic is feasible and can detect cancer at an early stage.
Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312963     DOI: 10.1016/j.ejim.2012.12.012

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

1.  Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening.

Authors:  Michael D Wirth; Heather M Brandt; Heather Dolinger; James W Hardin; Patricia A Sharpe; Jan M Eberth
Journal:  Colorectal Cancer       Date:  2014-06

2.  CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.

Authors:  Sivan Shamai; Ilana Nabiochtchikov; Sarah Kraus; Sally Zigdon; Dina Kazanov; Michal Itzhak-Klutch; Carmit Eizner; Nadir Arber; Ravit Geva
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

3.  Promoting early detection of melanoma during the mammography experience.

Authors:  A K Rzepecki; N Jain; Y Ali; L Chavez; J Choi; B Schlosser; E Liko-Hazizi; S M Friedewald; J K Robinson
Journal:  Int J Womens Dermatol       Date:  2017-07-05

4.  Effectiveness of One-Stop Screening for Colorectal, Breast, and Prostate Cancers: A Population-Based Feasibility Study.

Authors:  Joseph J Y Sung; Arthur K C Luk; Simon S M Ng; Anthony C F Ng; Peter K F Chiu; Emily Y Y Chan; Polly S Y Cheung; Winnie C W Chu; Sunny H Wong; Thomas Y T Lam; Samuel Y S Wong
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.